Zobrazeno 1 - 10
of 142
pro vyhledávání: '"Leboeuf NR"'
Autor:
Malik R; Harvard Medical School, Boston, Massachusetts; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts., Xiang DH; Harvard Medical School, Boston, Massachusetts; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts., Riew GJ; Harvard Medical School, Boston, Massachusetts; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts., Sanchez-Melendez S; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts; Ponce Health Sciences University, School of Medicine, Ponce, Puerto Rico., Afvari S; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts; New York Medical College, Valhalla, New York., LeBoeuf NR; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts; Department of Cutaneous Oncology, Dana Farber Cancer Institute, Boston, Massachusetts., Nambudiri VE; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts; Department of Cutaneous Oncology, Dana Farber Cancer Institute, Boston, Massachusetts. Electronic address: vnambudiri@bwh.harvard.edu.
Publikováno v:
Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2024 Oct; Vol. 91 (4), pp. 753-755. Date of Electronic Publication: 2024 Jun 21.
Autor:
Sun VH; Harvard Medical School, Boston, MA.; Cardiovascular Imaging Research Center, Massachusetts General Hospital, Boston, MA., Heemelaar JC; Harvard Medical School, Boston, MA.; Cardiovascular Imaging Research Center, Massachusetts General Hospital, Boston, MA.; Leiden University Medical Center, Leiden, the Netherlands., Hadzic I; Harvard Medical School, Boston, MA.; Artificial Intelligence in Medicine (AIM) Program, Mass General Brigham, Boston, MA.; Brigham and Women's Hospital, Boston, MA.; Maastricht University, Maastricht, the Netherlands., Raghu VK; Harvard Medical School, Boston, MA.; Cardiovascular Imaging Research Center, Massachusetts General Hospital, Boston, MA., Wu CY; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA.; Far Eastern Memorial Hospital, New Taipei City, Taiwan., Zubiri L; Harvard Medical School, Boston, MA.; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA., Ghamari A; Harvard Medical School, Boston, MA.; Cardiovascular Imaging Research Center, Massachusetts General Hospital, Boston, MA., LeBoeuf NR; Harvard Medical School, Boston, MA.; Department of Dermatology, Brigham and Women's Hospital, Boston, MA.; Center for Cutaneous Oncology, Dana-Farber Cancer Institute, Boston, MA., Abu-Shawer O; Department of Internal Medicine, Cleveland Clinic, Cleveland, OH., Kehl KL; Harvard Medical School, Boston, MA.; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, MA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Grover S; Harvard Medical School, Boston, MA.; Division of Gastroenterology, Hepatology, and Endoscopy, Brigham and Women's Hospital, Boston, MA., Singh P; Harvard Medical School, Boston, MA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Suero-Abreu GA; Harvard Medical School, Boston, MA.; Cardiovascular Imaging Research Center, Massachusetts General Hospital, Boston, MA.; Division of Cardiology, Massachusetts General Hospital, Boston, MA., Wu J; Harvard Medical School, Boston, MA.; Cardiovascular Imaging Research Center, Massachusetts General Hospital, Boston, MA., Falade AS; Internal Medicine Department, Massachusetts General Brigham Salem Hospital, Salem, MA., Grealish K; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA., Thomas MF; Division of Gastroenterology, Oregon Health and Science University, Portland, OR.; Department of Medicine, Oregon Health and Science University, Portland, OR.; Department of Cell, Developmental, and Cancer Biology, Oregon Health and Science University, Portland, OR., Hathaway N; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA., Medoff BD; Harvard Medical School, Boston, MA.; Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital, Boston, MA., Gilman HK; Harvard Medical School, Boston, MA.; Cardiovascular Imaging Research Center, Massachusetts General Hospital, Boston, MA., Villani AC; Harvard Medical School, Boston, MA.; Center for Immunology and Inflammatory Diseases (CIID), Massachusetts General Hospital Krantz Family Center for Cancer Research, Boston, MA.; Broad Institute of MIT and Harvard, Cambridge, MA., Ho JS; Harvard Medical School, Boston, MA.; Cardiovascular Imaging Research Center, Massachusetts General Hospital, Boston, MA., Mooradian MJ; Harvard Medical School, Boston, MA.; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA., Sise ME; Harvard Medical School, Boston, MA.; Division of Nephrology, Massachusetts General Hospital, Boston, MA., Zlotoff DA; Harvard Medical School, Boston, MA.; Division of Cardiology, Massachusetts General Hospital, Boston, MA., Blum SM; Harvard Medical School, Boston, MA.; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA.; Center for Immunology and Inflammatory Diseases (CIID), Massachusetts General Hospital Krantz Family Center for Cancer Research, Boston, MA.; Broad Institute of MIT and Harvard, Cambridge, MA., Dougan M; Harvard Medical School, Boston, MA.; Division of Gastroenterology, Massachusetts General Hospital, Boston, MA., Sullivan RJ; Harvard Medical School, Boston, MA.; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA., Neilan TG; Harvard Medical School, Boston, MA.; Cardiovascular Imaging Research Center, Massachusetts General Hospital, Boston, MA.; Division of Cardiology, Massachusetts General Hospital, Boston, MA., Reynolds KL; Harvard Medical School, Boston, MA.; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Sep 03, pp. JCO2400326. Date of Electronic Publication: 2024 Sep 03.
Autor:
Tang K; Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Rajeh A; Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Shaw KS; Department of Dermatology, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA., Nguyen N; Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Wan G; Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Hashemi KB; Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Castillo RL; Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Kwatra SG; Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, MD, USA., LeBoeuf NR; Dana Farber Cancer Institute, Department of Dermatology, Boston, MA, USA., Ann Vleugels R; Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Semenov YR; Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Publikováno v:
The British journal of dermatology [Br J Dermatol] 2024 Aug 14; Vol. 191 (3), pp. 460-462.
Autor:
Wan G; Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Chen W; Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA; Department of Biomedical Informatics, Harvard Medical School, Boston, MA, USA., Khattab S; Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Roster K; Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Nguyen N; Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Yan B; Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA; Department of Biomedical Informatics, Harvard Medical School, Boston, MA, USA., Rajeh A; Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Seo J; Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Rashdan H; Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Zubiri L; Department of Medicine, Division of Hematology-Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Hadfield MJ; Legorreta Cancer Center, Division of Hematology/Oncology, Department of Medicine, Warren Alpert Medical School, Brown University, Providence, RI, USA., Demehri S; Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Yu KH; Department of Biomedical Informatics, Harvard Medical School, Boston, MA, USA., Lotter W; Department of Medicine, Dana-Farber Cancer Institute, Boston, MA, USA., Gusev A; Department of Medicine, Dana-Farber Cancer Institute, Boston, MA, USA., LeBoeuf NR; Department of Dermatology, Center for Cutaneous Oncology, Brigham and Women's Hospital and Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Reynolds KL; Department of Medicine, Division of Hematology-Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Kwatra SG; Department of Dermatology, University of Maryland School of Medicine, Baltimore, MD, USA., Semenov YR; Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. Electronic address: ysemenov@mgh.harvard.edu.
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2024 Aug; Vol. 25 (8), pp. 1053-1069. Date of Electronic Publication: 2024 Jul 15.
Autor:
Maliga Z; Laboratory of Systems Pharmacology, Harvard Medical School, Boston, Massachusetts, USA., Kim DY; Harvard-MIT Health Sciences and Technology Program, Harvard Medical School, Boston, Massachusetts, USA., Bui AN; Department of Dermatology, The Center for Cutaneous Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, Massachusetts, USA., Lin JR; Laboratory of Systems Pharmacology, Harvard Medical School, Boston, Massachusetts, USA., Dewan AK; Department of Dermatology, Vanderbilt University Medical Center, Nashville, Tennessee, USA., Jadeja S; Program in Dermatopathology, Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA., Murphy GF; Program in Dermatopathology, Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA., Nirmal AJ; Laboratory of Systems Pharmacology, Harvard Medical School, Boston, Massachusetts, USA., Lian CG; Program in Dermatopathology, Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA., Sorger PK; Laboratory of Systems Pharmacology, Harvard Medical School, Boston, Massachusetts, USA., LeBoeuf NR; Department of Dermatology, The Center for Cutaneous Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, Massachusetts, USA. Electronic address: nleboeuf@partners.org.
Publikováno v:
The Journal of investigative dermatology [J Invest Dermatol] 2024 Aug; Vol. 144 (8), pp. 1887-1890.e5. Date of Electronic Publication: 2024 Feb 14.
Autor:
Gupta N; Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Kim DP; Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Conomikes A; Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Murad F; Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Nekhlyudov L; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Faling DW; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Frangos JE; Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., LeBoeuf NR; Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Ruiz ES; Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Publikováno v:
Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] [Dermatol Surg] 2024 Jul 01; Vol. 50 (7), pp. 611-615. Date of Electronic Publication: 2024 May 02.
Autor:
Wan G; Department of Dermatology, Massachusetts General Hospital, Boston, MA.; Harvard Medical School, Boston, MA., Khattab S; Department of Dermatology, Massachusetts General Hospital, Boston, MA., Leung BW; Department of Dermatology, Massachusetts General Hospital, Boston, MA.; Department of Dermatology, Brigham and Women's Hospital, Boston, MA.; Center for Cutaneous Oncology, Department of Dermatology, Dana-Farber Cancer Institute, Boston, MA., Zhang S; Department of Dermatology, Massachusetts General Hospital, Boston, MA., Nguyen N; Department of Dermatology, Massachusetts General Hospital, Boston, MA., Tran M; Department of Dermatology, Massachusetts General Hospital, Boston, MA., Lin C; Department of Dermatology, Massachusetts General Hospital, Boston, MA., Chang C; Department of Dermatology, Massachusetts General Hospital, Boston, MA., Alexander N; Department of Dermatology, Massachusetts General Hospital, Boston, MA., Jairath R; Department of Dermatology, Massachusetts General Hospital, Boston, MA., Phillipps J; Department of Dermatology, Massachusetts General Hospital, Boston, MA., Tang K; Department of Dermatology, Massachusetts General Hospital, Boston, MA., Rajeh A; Department of Dermatology, Massachusetts General Hospital, Boston, MA., Zubiri L; Department of Dermatology, Massachusetts General Hospital, Boston, MA., Chen ST; Department of Dermatology, Massachusetts General Hospital, Boston, MA., Demehri S; Department of Dermatology, Massachusetts General Hospital, Boston, MA., Yu KH; Harvard Medical School, Boston, MA., Gusev A; Center for Cutaneous Oncology, Department of Dermatology, Dana-Farber Cancer Institute, Boston, MA., Kwatra SG; Department of Dermatology, Johns Hopkins University, Baltimore, MD, USA., LeBoeuf NR; Harvard Medical School, Boston, MA.; Department of Dermatology, Brigham and Women's Hospital, Boston, MA.; Center for Cutaneous Oncology, Department of Dermatology, Dana-Farber Cancer Institute, Boston, MA., Reynolds KL; Department of Dermatology, Massachusetts General Hospital, Boston, MA.; Harvard Medical School, Boston, MA., Semenov YR; Department of Dermatology, Massachusetts General Hospital, Boston, MA.; Harvard Medical School, Boston, MA.
Publikováno v:
The British journal of dermatology [Br J Dermatol] 2024 Jun 20; Vol. 191 (1), pp. 117-124.
Autor:
Shimony S; Division of Hematologic Neoplasia, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Rabin Medical Center and Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Keating J; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA., Fay CJ; Department of Dermatology, Brigham and Women's Hospital, Boston, MA.; Center for Cutaneous Oncology, Dana-Farber Brigham Cancer Center, Boston, MA., Luskin MR; Division of Hematologic Neoplasia, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Neuberg DS; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA., LeBoeuf NR; Department of Dermatology, Brigham and Women's Hospital, Boston, MA.; Center for Cutaneous Oncology, Dana-Farber Brigham Cancer Center, Boston, MA., Lane AA; Division of Hematologic Neoplasia, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
Publikováno v:
Blood advances [Blood Adv] 2024 Jun 11; Vol. 8 (11), pp. 2803-2812.
Autor:
Chen ST; Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts, USA.; Mass General Cancer Center, Boston, MA, USA.; Harvard Medical School, Boston, Massachusetts, USA., Semenov YR; Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA., Alloo A; Department of Dermatology, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York, USA., Bach DQ; Department of Dermatology, Cedars Sinai, Los Angeles, California, USA., Betof Warner A; Memorial Sloan Kettering Cancer Center, New York, New York, USA., Bougrine A; Department of Dermatology, Université de Montréal, Montreal, Quebec, Canada., Burton L; Biogen Inc, Cambridge, Massachusetts, USA., Cappelli LC; Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Castells M; Harvard Medical School, Boston, Massachusetts, USA.; Department of Medicine, Division of Allergy and Clinical Immunology, Brigham and Women's Hospital, Boston, Massachusetts, USA., Cohen J; Harvard Medical School, Boston, Massachusetts, USA.; Department of Medical Oncology, Centers for Cutaneous and Melanoma Oncology, Dana-Farber Cancer Insititute, Boston, MA, USA., Dewan AK; Vanderbilt University Medical Center, Nashville, Tennessee, USA., Fadden R; Mass General Cancer Center, Boston, MA, USA., Guggina L; Harvard Medical School, Boston, Massachusetts, USA.; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Center for Cutaneous Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Hegde A; UAB, Birmingham, Alabama, USA., Huang V; Department of Dermatology, University of California Davis, Davis, California, USA., Johnson DB; Vanderbilt University Medical Center, Nashville, Tennessee, USA., Kaffenberger B; Department of Dermatology, Ohio State University Wexner Medical Center, Columbus, Ohio, USA., Kroshinsky D; Department of Dermatology, Duke University Medical Center, Durham, North Carolina, USA., Kwatra S; Johns Hopkins Department of Dermatology, Baltimore, Maryland, USA., Kwong B; Stanford University School of Medicine, Stanford, UK., Lacouture ME; MSKCC, New York, New York, USA.; NYU Langone Health, New York, New York, USA., Larocca C; Harvard Medical School, Boston, Massachusetts, USA.; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Center for Cutaneous Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Leventhal J; Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut, USA., Markova A; Memorial Sloan Kettering Cancer Center, New York, New York, USA., McDunn J; Project Data Sphere ®, Morrisville, North Carolina, USA., Mooradian MJ; Mass General Cancer Center, Boston, MA, USA.; Harvard Medical School, Boston, Massachusetts, USA., Naidoo J; Johns Hopkins University, The Bloomberg-Kimmel Institute for Cancer Immunotherapy, Baltimore, Maryland, USA., Choi J; Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA., Nambudiri V; Harvard Medical School, Boston, Massachusetts, USA.; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Center for Cutaneous Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Nelson CA; Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut, USA., Patel AB; Department of Dermatology, Internal Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Pimkina J; Harvard Medical School, Boston, Massachusetts, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Rine J; Project Data Sphere ®, Morrisville, North Carolina, USA., Rubin KM; Mass General Cancer Center, Boston, MA, USA., Sauder M; DIvision of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada.; Princess Margaret Cancer Centre, Toronto, Ontario, Canada., Shaigany S; Department of Dermatology, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York, USA., Shariff A; Department of Medicine, Duke University School of Medicine, Durham, NC, USA., Sullivan RJ; Mass General Cancer Center, Boston, MA, USA.; Harvard Medical School, Boston, Massachusetts, USA.; Massachusetts General Hospital, Boston, Massachusetts, USA., Zubiri L; Mass General Cancer Center, Boston, MA, USA.; Harvard Medical School, Boston, Massachusetts, USA.; Massachusetts General Hospital, Boston, Massachusetts, USA., Reynolds KL; Mass General Cancer Center, Boston, MA, USA.; Harvard Medical School, Boston, Massachusetts, USA.; Massachusetts General Hospital, Boston, Massachusetts, USA., LeBoeuf NR; Harvard Medical School, Boston, Massachusetts, USA nleboeuf@bwh.harvard.edu.; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Center for Cutaneous Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2024 Apr 10; Vol. 12 (4). Date of Electronic Publication: 2024 Apr 10.
Autor:
Bang AS; Department of Dermatology, Weill Cornell Medicine, New York, NY, USA.; Dermatology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Dermatology, Stanford University, Palo Alto, CA, USA., Fay CJ; Dermatology of Dermatology, Harvard Medical School, Center for Cutaneous Oncology, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Boston, MA, USA., LeBoeuf NR; Dermatology of Dermatology, Harvard Medical School, Center for Cutaneous Oncology, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Boston, MA, USA., Etaee F; Department of Dermatology, Yale School of Medicine, New Haven, CT, USA., Leventhal JS; Department of Dermatology, Yale School of Medicine, New Haven, CT, USA., Sibaud V; Oncodermatology Department, Institut Universitaire du Cancer, Toulouse Oncopole, Toulouse, France., Arbesman J; Department of Dermatology, Cleveland Clinic, Cleveland, OH, USA., Wang JY; Department of Dermatology, Stanford University, Palo Alto, CA, USA., Kwong BY; Department of Dermatology, Stanford University, Palo Alto, CA, USA. bernicek@stanford.edu.
Publikováno v:
Breast cancer research and treatment [Breast Cancer Res Treat] 2024 Apr; Vol. 204 (3), pp. 643-647. Date of Electronic Publication: 2024 Jan 15.